These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 340026)
1. Demonstration of cellular and humoral immunity to transplantable carcinomas derived from the respiratory tract of rats. Jamasbi RJ; Nettesheim P; Kennel SJ Cancer Res; 1978 Feb; 38(2):261-7. PubMed ID: 340026 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of cross-reacting tumor rejection antigens in chemically induced respiratory tract carcinomas in rats. Jamasbi RJ; Nettesheim P Cancer Res; 1977 Nov; 37(11):4059-63. PubMed ID: 71203 [TBL] [Abstract][Full Text] [Related]
3. Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture. Jamasbi RJ; Nettesheim P Cancer Res; 1979 Jul; 39(7 Pt 1):2466-70. PubMed ID: 87265 [TBL] [Abstract][Full Text] [Related]
4. Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate. Lande IJ; Feldbush TL; Lubaroff DM Invest Urol; 1980 Mar; 17(5):419-24. PubMed ID: 7358506 [TBL] [Abstract][Full Text] [Related]
5. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. Cihak J; Ziegler HW; Kölsch E Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346 [TBL] [Abstract][Full Text] [Related]
6. Effects on tumor growth in vivo by manipulation of the tumor immune response. Sjögren HO Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816 [No Abstract] [Full Text] [Related]
8. Common tumor rejection antigens in methylcholanthrene-induced squamous cell carcinomas of mice detected by tumor protection and a radioisotopic footpad assay. Economou GC; Takelchi N; Boone CW Cancer Res; 1977 Jan; 37(1):37-41. PubMed ID: 63329 [TBL] [Abstract][Full Text] [Related]
9. Demonstration of tumor-specific antigen in squamous cell carcinomas of the lung, using an established bronchial carcinoma line E 14. Short communication. Auchmann M; Breit P; Cerni C; Micksche M; Vetterlein M; Wrba H Osterr Z Onkol; 1974; (1):26-8. PubMed ID: 4480616 [No Abstract] [Full Text] [Related]
10. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas. Alley CD; Snodgrass MJ Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425 [TBL] [Abstract][Full Text] [Related]
12. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice. Jose DG; Good RA Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154 [No Abstract] [Full Text] [Related]
13. Time lapse cinematographic demonstration of humoral and cell mediated immunity in squamous cell carcinoma of the lung. Vetterlein M; Auchmann M; Breit P; Cerni C; Micksche M; Wrba H Osterr Z Onkol; 1976; 3(4):99-102. PubMed ID: 1037019 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines. Edelman AS; Xue B; Sanchez P; Thorbecke GJ J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898 [TBL] [Abstract][Full Text] [Related]
15. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors]. Stiller-Winkler R; Stark M; Idel H Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233 [TBL] [Abstract][Full Text] [Related]
16. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach. Tong AW; Lee J; Stone MJ Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911 [TBL] [Abstract][Full Text] [Related]
17. Generation of monoclonal antibodies against human lung squamous cell carcinoma and adenocarcinoma using mice rendered tolerant to normal human lung. Hanai N; Shitara K; Yoshida H Cancer Res; 1986 Sep; 46(9):4438-43. PubMed ID: 3731100 [TBL] [Abstract][Full Text] [Related]
18. Expression of various tumor-specific antigens in polyoma virus-induced tumors. Ting CC; Lavrin DH; Takemoto KK; Ting RC; Herberman RB Cancer Res; 1972 Jan; 32(1):1-6. PubMed ID: 4332472 [No Abstract] [Full Text] [Related]
19. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
20. Specific and nonspecific stimulation of resistance to the growth and metastasis of the line 1 lung carcinoma. Yuhas JM; Toya RE; Wagner E Cancer Res; 1975 Jan; 35(1):242-4. PubMed ID: 1109793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]